Supplemental Table 8: Information on patients and primates from which samples were obtained.						
Sample	Species	Sex	Age	Medications	Cell composition	Analyses performed
Y7	Homo sapiens	Female	75	Unknown	"90% chief cells, 10% transitional cells"	"scRNAseq, H&E, IF"
Y9	Homo sapiens	Female	66	Unknown	"70% chief cells, 30% transitional cells"	"scRNAseq, H&E, IF"
Y11	Homo sapiens	Female	53	Unknown	"80% transitional cells, 20% oxyphilic cells"	"scRNAseq, H&E, IF"
Y13	Homo sapiens	Male	57	Unknown	~100% oxyphilic cells	"scRNAseq, H&E, IF"
Primate 1	Macaca mulatta	Female	23	Daily probiotics	Unknown	scRNAseq
Primate 2	Macaca mulatta	Female	22	Medroxyprogesterone acetate once every 3 months since 2012 for endometriosis	Unknown	scRNAseq
Primate 3	Macaca mulatta	Female	22	Medroxyprogesterone acetate once every 3 months since 2020 for endometriosis	Unknown	scRNAseq
Primate 4	Macaca mulatta	Female	23	No long-term medications	Unknown	scRNAseq
Primate 5	Macaca mulatta	Male	27	"Daily meloxicam for osteoarthritis, insulin for Type I Diabetes Mellitus"	"~80% transitional cells, ~10% chief cells, ~10% clear cells"	"H&E, IF"
Primate 6	Macaca mulatta	Female	28	"Daily prednisone, citirizine for chronic allergic dermatitis"	"70% chief cells, 30% transitional cells"	H&E
Primate 7	Macaca mulatta	Male	6	No long-term medications	"~99% chief cells, ~1% transitional cells"	H&E
Priamte 8	Macaca mulatta	Female	28	"Metformin for 1 year in 2018, piglitazone for 4 months in 2019, insulin daily since 2020 for Type I diabetes"	"70% chief cells, 25% transitional cells, 5% oxyphils"	H&E